Luminal breast epithelial cells of BRCA1 or BRCA2 mutation carriers and noncarriers harbor common breast cancer copy number alterations

BRCA1或BRCA2基因突变携带者和非携带者的乳腺管腔上皮细胞均存在常见的乳腺癌拷贝数变异。

阅读:6
作者:Marc J Williams # ,Michael U J Oliphant # ,Vinci Au # ,Cathy Liu ,Caroline Baril ,Ciara O'Flanagan ,Daniel Lai ,Sean Beatty ,Michael Van Vliet ,Jacky Ch Yiu ,Lauren O'Connor ,Walter L Goh ,Alicia Pollaci ,Adam C Weiner ,Diljot Grewal ,Andrew McPherson ,Klarisa Norton ,McKenna Moore ,Vikas Prabhakar ,Shailesh Agarwal ,Judy E Garber ,Deborah A Dillon ,Sohrab P Shah ,Joan S Brugge ,Samuel Aparicio

Abstract

The prevalence and nature of somatic copy number alterations (CNAs) in breast epithelium and their role in tumor initiation and evolution remain poorly understood. Using single-cell DNA sequencing (49,238 cells) of epithelium from BRCA1 and BRCA2 carriers or wild-type individuals, we identified recurrent CNAs (for example, 1q-gain and 7q, 10q, 16q and 22q-loss) that are present in a rare population of cells across almost all samples (n = 28). In BRCA1/BRCA2 carriers, these occur before loss of heterozygosity (LOH) of wild-type alleles. These CNAs, common in malignant tumors, are enriched in luminal cells but absent in basal myoepithelial cells. Allele-specific analysis of prevalent CNAs reveals that they arose by independent mutational events, consistent with convergent evolution. BRCA1/BRCA2 carriers contained a small percentage of cells with extreme aneuploidy, featuring loss of TP53, BRCA1/BRCA2 LOH and multiple breast cancer-associated CNAs. Our findings suggest that CNAs arising in normal luminal breast epithelium are precursors to clonally expanded tumor genomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。